PAC INFECTO-1 C2
Contenido
REFERENCIAS
HEPATITIS A
  1. American Academy of Pediatrics. Hepatitis A. En: Peter G, ed-1997 Red Book: Report of the Committee on Infectious Diseases. 24 th ed. Elk Grove Village, IL: American Academy of Pe-diatrics; 1997, p 157.

  2. Bruguera M, Bayas JM, Vilella A, Tural C, Gonzalez A, Vidal J, Dal Re R, Salleras L. Immunogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine 1996; 14(15): 1407-11.

  3. Bustamante-Calvillo ME, Velázquez CFR, Padilla NL, Alvarez-Muñoz MT, Moreno AL, Martínez GMC, Guizcafré GH, Muñoz O. Seroepi-demiología de la infección por el virus A de la hepatitis en comunidades de la frontera sur del Estado de Chiapas. Bol Med Hosp Infant Méx 1986; 43: 735-41.

  4. Cromeans T, Nainan O, Fields HA, Favorov MO, and Margolis HS. Hepatitis A and E viruses, En: Hui YH, Gorham JR, Mucell KD, Cliver DO, ed. Foodborne Disease Handbook. eds. New York Marcel Dekker, 1994, p 1-56.

  5. Erkan T, Kutlu T, Cullu F, Tumay GT. A case of vertical transmission of hepatitis A virus infection. Acta Pediatrica 1998; 87(9): 1008-9.

  6. Gil A, Gonzalez A, Dal Re R, Dominguez V, Astasio P, Aguilar L. Detection of antibodies against hepatitis A in blood spots dried on filter paper. Is this a reliable method for epide-miological studies? Epidemiol Infect 1997; 118(2): 189-91.

  7. Hadler SC. Global impact of hepatitis A virus infection changing patterns. En: Hotlinger FB, eds. Lemon SM, Margolis HS. Viral hepatitis and liver disease. Baltimore, Williams and Wilkins, 1991, p 14-20.

  8. Korzaia LI, Shevtsova ZV, Lapin BA, Krylova RI, Dzhelieva ZN. Secundary infection with hepatitis A in Rhesus monkeys after experimental inocu-lation. Voprosy Virusologii 1998; 43(4): 158-63

  9. Kumate J, Alvisouri AM, Isibasi A. Serologic survey of hepatitis A antibodies in Mexican children. Bull PAHO 1982; 16: 156-60.

  10. Lemon SM, Shapiro CN. The value of immu-nization against hepatitis A. Infect Agents Dis 1994; 3: 38-49.

  11. Manns MP, Schuler A. Risk of hepatitis A superinfection in patients with underlying liver disease. Acta Gastroenterologica Belgica 1998; 61(2): 206-9.

  12. Margolis HS, Alter MJ, Hadler SC.Viral hepatitis. En:Evans AS, Kaslow RA. Viral Infections of humans. Epidemiology and control. 4th ed. New York, Plenum Medical Book Company, 1997, p. 363-418.

  13. Ochnio JJ, Scheifele DW, Ho M, Mitchell LA. New, ultrasensitive enzyme immunoassay for detecting vaccine and disease induced hepatitis A virus-specific immunnnoglobulin G in saliva. J Clin Microbiol 1997; 35(1): 98-101.

  14. Poovorawan Y. Changing epidemiology and prevention of hepatitis A virus infection. Chung-Hua Min Kuo Hsiao Erch Ko y Hsueh Hui Tsa Chih 1998; 39(3): 139-45.

  15. Ramírez MJA, Cervantes BR, Jiron CR, Oyervides GCI, Mata RN y cols. Prevalence of antibodies against hepatitis A virus (HVA) in a population of Mexican children. Acta Gastroenterologica Latinoamericana 1997; 27(2): 99-102.

  16. Ruíz-Gómez J, Bustamante-Calvillo ME. Hepatitis A antibodies: prevalence and persistence in a group of Mexican children. Am J Epidem 1985; 121: 116-119.

  17. Taylor MB. Molecular epidemiology of South African strains of hepatitis A virus:1982-1996. J Med Virol 1997; 51(4):273-9.

  18. Vento S, Garofano T, Renzini C, Caineli F, Ghironzi G, Ferraro T, Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New Engl 1998; 338(5): 286-90.

  19. Zachoval R, Dienhardt. Natural history and experimental models. En: Zuckerman AJ, Thomas HC. Viral Hepatitis. Scientific basis and clinical management. ed. New York, Churchill Livingstone. l993. p. 35-53.


HEPATITIS B
  1. Alvarez-Muñoz MT, Vázquez-Rosales G, Torres-López J, Arredondo-García JL, Bustamante-Calvillo ME, Del Rey-Pineda G y cols. Infection of pregnant women with hepatitits B and C viruses and risks for vertical transmission. Arch Med Res 1997;28:415-419.

  2. Alvarez-Muñoz MT, Vázquez-Rosales G, Busta-mante-Calvillo ME, Del Rey-Pineda G, Arredon-do-García JL, Muñoz-Hernández O. Prevalencia de marcadores serológicos para el virus B y C de la hepatitis en una cohorte de embarazadas del Valle de México. Bol Med Hosp Infant Mex 1995;52:143-147.

  3. American Academy of Pediatrics. Hepatitis B. En: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th edition. Elk Grove Village, IL: American Academy of Pediatrics 1997:247-259.

  4. Boletín Informativo PAI. Programa ampliado de inmunización en las Américas. Año XX. Diciem-bre 1998.

  5. Juarez-Figueroa LA, Uribe Salas FJ, Conde-González CJ, Hernández-Avila M, Hernández-Nevarez P, Uribe-Zuñiga P, del Río-Chiriboga C. Hepatitis B markers in men seeking human immunodeficiency virus antibody testing in Mexico City. Sex Transm Dis 1997;24:211-217.

  6. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342:1335-1339.

  7. Pita-Ramírez L, Torres-Ortiz GE. Prevalencia de anticuerpos virales y reaginas luéticas en donadores de sangre de un hospital. Rev Invest Clin 1997;49:475-80.

  8. Vázquez-Rosales JG, Mendoza-Guevara L, Alvarez-Muñoz MT, Aguilar A, Morales A, Rodríguez F, Solórzano-Santos F et al. Comparison of the recombinant vaccine against hepatitits B virus in dialized and non-dialized children with CRF using different doses and routes of administration. Adv Peritoneal Dialysis 1997;13:291-96.

  9. Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet 1993;342:1340-1344.


HEPATITIS POR VIRUS C
  1. Alter MJ. The epidemiology of hepatitis C in the West. Semin Liver Dis1995;15:5-14

  2. Choo QI, Kuo G Weiner AJ et al. Isolation of cDNA clone derived from a blood borne non-A non –B viral hepatitis genome. Science 1989; 224:359-62.

  3. Davis G L, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interven-tional Therapy group. N Engl J Med 1998; 339:1493-9.

  4. DiBiscegli AM, Goodman ZD, Ishak KG, et al. Long term clinical and histopatological follow-up of chronic post-transfusion hepatitis. Hepo-tology 1991;14:969-74.

  5. Lampertico P, Rumi MG, Romeo R, et al. A multicenter randomized controlled trial of recombinant interferon alpha 2b in patients with acute transfussion asociated hepatitis C. Hepa-tology 1994;19:19-22.

  6. Lok AS, Gunaratnam NT. Diagnosis of hepatitis C. Hepatology 1997;26 (suppl 1):48S-56S.

  7. McHutchinson JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Internstiond Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1485-92.

  8. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997;26 (suppl 1):57S-61S.

  9. Poynard T, Marcellini P, Lee SS, et al. Rando-mized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International hepatitis Interventional Therapy Group (IHIT). Lancet 1998;352:1426-32.

  10. Poynard T, Leroy V, Cohard M, et al. Metaanalysis of interferon randomized trials in the treatment of viral hepatitis C; effects of dose and duration. Hepatology 1996;24:778-89.

  11. Purcell R. The hepatitis C overview. Hepatology 1997;26 (suppl 1):11S-14S.

  12. Seef LB. Natural history of hepatitis C. Hepa-tology 1997 (suppl 1):21S-28

  13. Serfaty L, Nousbaum JB, Eighouzzi MH, et al. Prevalence severity and risk factors of liver diseases in blood donors positive in a second generation anti hepatitis C virus screning test. Hepatology 1995;21:725-29.


HEPATITIS D (DELTA)

  1. Bichko VV, Khudyayakov E, Taylor JM. A novel form of hepatitis delta antigen. J Virol 1996;70(5): 3248-51.

  2. Cock KM, Govindarjan S, Chin K , Redeker AG. Delta hepatitis in the Los Angleles area: a report of 126 cases. Ann Intern Med 1986;105:108-14.

  3. Farci P, Mandras A, Coiana A, Lai ME, Desmet V, Van-Eyken, et al. Treatment of chronic hepatitis D with interferon alfa 2a N Engl J Med 1994; 330(2):88-94.

  4. Garasinni MA. Hepatitis D: Curso clínico y serología. Rev Gastroenterol Mex 1995; 60(4 supl 2): 43-5.

  5. Hadziyannis SJ. Review: hepatitis delta. J Gastroenterol Hepatol 1997;12(4): 289-98

  6. Hoofnagle JH. Therapy of acute and chronic hepatitis. Adv Intern Med 1994; 39: 241-75.

  7. Hoofnagle JH . Type D ( Delta ) hepatitis. JAMA 1989 ; 261(9): 1321-25.

  8. Muñoz LE. Virus Delta. Rev Gastroenterol Mex 1995; 60(4 supl 2):40-2.

  9. Jaw-Ching W, Trong-Zong Ch, Yi-Sin H, et al. Natural history of hepatitis D viral supe-rinfección: significance of viremia detected by Polimerase chain reaction. Gastroenterology 1995;108:796-802.

  10. Navascues CA, Rodriguez M, Storrio NG, Sala P, Linares A, Suarez A, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995; 90(11):1981-4.

  11. Negro F, Rizzetto M. Diagnosis of hepatitis Delta virus infección. J Hepatol 1995; 22(suppl 1 ): 136-9.

  12. Saracco G, Rizzetto M. A practical guide to the use of interferons in the management of hepatitis. Drugs 1997;53(1):74-85.

  13. Wu JC, Chen CM, Sheen IJ, et al. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepa-tology 1995;22(6):1656-60.


HEPATITIS VIRAL TIPO E
  1. Alvarez-Muñoz MT, Torres J, Damasio SL, Gómez A, Fernández QG, Tapia-Conyer R, Muñoz O. Seroepidemiology of hepatitis E virus infection in subjects 1 to 29 years of age in Mexico. Archives of Medical Research 1999 (En prensa).

  2. Barriga AG, Castillo TNP, Dehesa TR. Seroepi-demiología de la hepatitis tipo E en México. Rev Mex Patol Clín 1996; 44: 148-151.

  3. Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS, Szmuness W. Efficacy of hepatitis B immunoglobulin for prevention of perinatal transmission of the hepatitis B virus: Final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983; 3: 135-141.

  4. Bernal Reyes R, Licona- Solis JE. Seroepidemiology of hepatitis E in the State of Hidalgo. Rev Gastroenterol Mex 1996; 61(3): 233-8.

  5. Bradley DW, Krawczynski K, Purdy MA. Hepatitis E. En: Zuckerman AJ, Thomas HC. Viral hepatitis. Scientific basis and clinical manage-ment. New York, Churchill Livingstone. 1993, p. 373-404.

  6. Cromeans T, Nainan O, Fields HA, Favorov MO, Margolis HS. Hepatitis A and E viruses. En: Hui YH, Gorham JR, Mucell KD, Cliver DO, eds. Food-borne Disease Handbook. New York, Marcel Dekker, 1994. p. 1-56.

  7. He J, Hoffman SL, Hayes CG. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine 1997; 15(4): 357-62.

  8. Hsieh SY, Yang PY,Ho YP, Chu CM, Liaw YF. Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in Taiwan. J Med Virol 1998; 55(4): 300-4.

  9. Khuroo MS, Duermeyer W, Zargar SA, Ahanger MA, Shah MA. Acute sporadic non-A, non-B hepatitis in India. Am J Epidemiol 1983; 118: 360-364.

  10. Li TC, Yamakawa Y, Suzuki K, Tatsumi M, Razak MA, Uchida T, Takeda N, Miyamura T. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997; 71(10): 7207-13.

  11. Maneerat Y, Clayson ET, Myint KS, Young GD, Innis BL. Experimental infection of the labo-ratory rat with the hepatitis E virus. J Med Virol 1996; 48(2): 121-8.

  12. Margolis HS, Alter MJ, Hadler SC. Viral hepatitis. En: Evans AS, Kaslow RA Viral infections of humans. Epidemiology and Control. 4th, eds. New York, Plenum Medical Book Company, 1997. p. 363-418.

  13. Meng XJ, Halbur PG, Shapiro MS, Govindarajan S, Bruna JD, Mushahwar IK, Purcell RH, Emerson SU. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virology 1998; 72(12):9714-21.

  14. Miller MJ. Viral taxonomy. Clin Infect Dis 1995; 21: 280.

  15. Redlinger T, O’Rourke K, Nickey L, Martínez G. Elevated hepatitis A and E seroprevalence rates in a Texas/Mexico border community. Texas Medicine 1998; 94(5): 68-71.

  16. Tomar BS. Hepatitis E in India. Chung-Hua Min Kuo Hsiao Erh Ko i Hsueh Hui Tsa Chih 1998;39(3): 150-6.

  17. Tsarev SA, Tsareva TS, Emerson SU, Govin-darajan S, Shapiro M, Gerin JL, Purcell RH. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997; 15(17-18): 1834-8.

  18. Velazquez O, Stetler HC, Avila C, Ornelas G, Alvarez C, Hadler SC, Bradley DW, Sepulveda J. Epidemic transmission of enterically trans-mitted non-A, non-B hepatitis in México, 1986-1987. JAMA 1990; 263: 3261-3285.


HEPATITIS G
  1. Blair CS, Davidson F, Lycett C et al. Prevalence, incidence and clinical characteristics of hepatitis G virus /GB virus C infection in Scottish blood donors. J Infect Dis 1998;178: 1779-82.

  2. Bukh J, Kim JP, Govindarajan S et al. Exper-imental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis 1998;177:855-62.

  3. Kondo Y, Mizokami M, Nakano T et al. Analysis of conserved ambisense sequences within GB virus C. J Infect Dis 1998; 178: 1185-8

  4. Kondo Y, Mizokami M, Nakano T et al. Genotype of GB virus C/hepatitis G virus by molecular evolutionary analysis. Virus Res 1997; 52: 221-30.

  5. Lin HH, Kao J, Yeh Kuo-Yi et al. Mother to infant transmission of GB virusC/hepatitis G virus: the role of high-titered maternal viremia and mode of delivery. J Infect Dis 1998;177:1202-6

  6. Linnen J, Wages J, Zhang-Keck ZY et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271: 505-8

  7. Ross RS, Viazov S, Schmitt U et al. Distinct prevalence of antibodies to the E2 protein of GB virus C/ hepatitis G virus in different parts of the world. J Med Virol 1998;54: 103-6.

  8. Sarrazin C, Roth WK, Zeuzem S. Heterosexual transmission of GB virus/hepatitis G virus infection. Eur J Gastroenterol-Hepatol 1997; 9: 1117-20

  9. Simons JN,Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-9.

  10. Tanaka E, Tacke M, Kobayashi M et al. Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic. J Clin Microciol 1998; 36:110-4.
Contenido
Copyright © 2005 Dr. Scope. Derechos Reservados.
Diseño y Programación: Educación Médica Contínua